TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›ULS
ULS logo

ULS

UL Solutions Inc.

Next earnings Aug 3, 2026 · consensus $0.57 EPS, $824M rev

Last earnings +16.2% on 2026-05-05

Hold
$96.99
▼ -3.08%
$96.99▲ +35.29%
over 1Y
L $62.21H $104.74
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-3.1%
1W+1.2%
1M-0.8%
3M+14.8%
YTD+20.3%
1Y+35.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Overvalued
Filings
Watch
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 17 analysts
Buy

A wide-moat safety-science leader with strong returns, but a 57x multiple already prices in the steady growth.

Revenue (FY2025) $3.05B · FY2025

The read

Middling fundamentals and a rich price (~76% above fair value) leave little margin of safety — a wait-and-see.

UL Solutions is a high-quality testing, inspection and certification (TIC) franchise built on the 130-year-old UL brand, serving 80,000+ customers across 110 countries with 650+ accreditations against 4,000+ standards. The economics are excellent: FY2025 revenue grew 6.4% to $3.05B, operating income rose 13.0% to $522M (a 17.1% operating margin), and the business earns a 25.8% return on equity while converting earnings to cash strongly — operating cash flow of $600M (+14.5%) on $197M of capex. The TIC model benefits from structural tailwinds the 10-K cites: emerging technologies, evolving safety regulations, more global trade and shorter product lifecycles all expand the outsourced testing market.

The balance sheet is improving in lockstep. Long-term debt fell 29.0% to $491M with no current portion, total liabilities dropped 12.9%, and equity jumped 39.6% to $1.26B as retained earnings grew 88.0% to $470M. The company also pays a growing dividend ($104M, +4.0%). This is a steady compounder, not a turnaround.

Is ULS a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~90d expiry
  • Long 100 shares @ ~96.99
  • Short call 102 @ ~3.74 est
debit $9,325max +$875max −$9,324BE 93.25

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25
Revenue$2.52B$2.68B$2.87B$3.05B
Gross profit————
Operating income$412M$368M$462M$522M
Net income$293M$260M$326M$325M
Diluted EPS$1.47$1.30$1.62$1.60
Net margin11.6%9.7%11.4%10.6%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$19.7B
EV / EBITDA27.8
EV / Sales6.5
EV / FCF49.0
P / FCF48.5
PEG (trailing)—
Earnings yield1.7%
FCF yield2.1%

Quality & risk

ROIC (est.)23.5%
Free cash flow$403M
Total debt$491M
Net cash-$196M
Altman Z-Score9.17 safe
Piotroski F-Score6/8

Capital returns

Buyback yield—
Dividend yield (est.)0.5%
Shareholder yield0.5%
Shares Δ YoY+0.4%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-06-03
  2. 8-K Shareholder vote2026-05-22
  3. 8-K Earnings results2026-05-05
  4. 10-Q Quarterly report2026-05-05
  5. 8-K Reg FD disclosure2026-04-13
  6. DEF 14A Proxy statement2026-04-02
  7. 8-K Earnings results2026-02-19
  8. 10-K Annual report2026-02-19
  9. 8-K Other event2025-12-05

Recent filings

all on EDGAR ↗
4Period ending 2026-07-012026-07-02open ↗144Filing2026-07-01open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueF
GrowthC-
ProfitabilityA-
Financial healthB+
MomentumB
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$22.97

Overvalued -76% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.60 × (8.5 + 1.5 × 3.0% growth) × 1.10 quality = 14.4× multiple. An estimate, not a price target.

62.2152-week104.74
Revenue
$3.05B
+6.4% YoY
Net margin
10.6%
ROE
25.8%
P/E
60.6

SEC fundamentals · FY 2025

'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$3.05B+6.4%
Net income$325M-0.3%
Operating income$522M+13.0%
Diluted EPS$1.60-1.2%
Cash & equivalents$295M-1.0%
Total assets$2.92B+4.3%
Total liabilities$1.63B-12.9%
Stockholders' equity$1.26B+39.6%
Op.: 17.1%L/E: 1.29x

Frequently asked

Is UL Solutions Inc. (ULS) a buy?
ULS currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. A wide-moat safety-science leader with strong returns, but a 57x multiple already prices in the steady growth.
What is ULS's fair value?
A Modified-Graham model based on ULS's SEC fundamentals estimates a fair value of about $22.97. It is an estimate from reported earnings, not a price target.
Is ULS overvalued or undervalued?
Against a Modified-Graham fair-value estimate, ULS currently appears overvalued relative to its SEC-grounded earnings power.
What is UL Solutions Inc.'s quality score?
ULS scores 64.34210535168573/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001901440, latest 10-Q filed 2026-05-05) · EODHD · Proprietary analysis · as of 6/21/2026, 8:42:16 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:42 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 5 sales

2026-07-01
Scanlon Jennifer F.
President and CEO
Sell4.80K @ $97.92$470K
2026-07-01
Scanlon Jennifer F.
President and CEO
Sell3.60K @ $99.05$357K
2026-07-01
Scanlon Jennifer F.
President and CEO
Sell1.20K @ $100.34$120K
2026-07-01
Scanlon Jennifer F.
President and CEO
Sell2.60K @ $101.05$263K
2026-07-01
Scanlon Jennifer F.
President and CEO
Sell300.00 @ $101.74$30.5K

Held by tracked funds

Form 13F · SEC · quarterly
Soros Fund Management395K sh$33.9M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Earnings history

beat/miss · move
2026-05-05Beat +20.1% est▼ -1.43%8-K ↗
2026-02-19Beat +16.6% est▲ +4.74%8-K ↗
2025-11-04Beat +18.6% est▲ +1.16%8-K ↗
2025-08-05Miss -4.9% est▲ +0.69%8-K ↗
2025-05-06—▲ +3.69%8-K ↗
2025-02-20—▲ +0.59%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score64 vs 67
Revenue growth6.4% vs 7.5%
Net margin10.6% vs 10.0%
Return on equity25.8% vs 12.0%
P/E60.6 vs 26.2